Zydus Cadila vax found safe in clinical trials
NEW DELHI: Ahmedabad- based pharmaceutical company Zydus has announced that its plasmid DNA vaccine to prevent COVID-19, ZyCoV-D was found to be safe, well tolerated and immunogenic in the Phase I/II clinical trials. The company is now planning to initiate Phase III clinical trial in around 30,000 volunteers upon receiving necessary approvals. The Phase II […]